In Milestone for Women’s HIV Prevention, European Medicines Agency Adopts Positive Opinion on Monthly Vaginal Ring to Reduce HIV Risk
Published on July 24, 2020
The monthly ring is the first long-acting HIV prevention product and is designed to help address women’s unmet need for new methods given the persistently high rates of HIV they face, especially in sub-Saharan Africa. International Partnership for Microbicides